The October content release includes the following updates:

Year-To-Date EMA and FDA statistics:

• 100,612 new pages
• 5,254 new documents
• 196,291 new extracted PK data observations
• 66,030 new extracted safety data observations
• 50 new drugs

FDA Approval Packages:

• 7 new drugs:
  • Belatacept
  • Ezogabine
  • Fidaxomicin
  • Hydrocodone; Chlorpheniramine; Pseudoephedrine
  • Hydrocodone; Pseudoephedrine
  • Rilpivirine Hydrochloride
  • Telaprevir
• 901 new FDA Approval Documents
• 18,961 new pages of FDA Approval Documents

Extracted PK data observations:

• 20,575 new extracted PK data lines

Extracted Safety data observations:

• 12,550 new extracted safety data lines

Published Toxicity Database:

• 1,838 new safety records

AERS (post-marketing) reports:

• 176,415 new reports

FDA Advisory Committee Documents:

• 324 new documents
• 15,288 new pages

The new totals for PharmaPendium are:

• 1,506,054 pages of FDA Approval documents (Including FDA Classic Collection)
• 63,905 documents of FDA Approval documents (Including FDA Classic Collection)
• 4089 drugs with data in PharmaPendium
• 1,043,649 extracted safety data lines
• 1,224,416 extracted PK data lines
• 4,130,298 AERS (post-marketing) reports
• 4,691 documents / 82,421 pages of EMA Approval documents
• 10,175 documents / 417,321 pages of FDA Advisory Committee Meeting documents
• 10,906 documents / 308,015 pages of FDA Classic Collection